Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Humana Inc (HUM) vs Uranium Energy Corp (UEC) Price & Performance

Humana IncTrade
Uranium Energy CorpTrade

Price performance (Past 24H)

Key statistics

Humana Inc vs Uranium Energy Corp — how do they compare? Humana Inc trades at $433.13 (market cap $46.49B), while Uranium Energy Corp trades at $9.23 (market cap $4.53B). The key difference: Humana Inc is far larger — about 10.3× Uranium Energy Corp's market cap, and Humana Inc pays a 0.91% dividend while Uranium Energy Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Uranium Energy Corp for 37 Days on average.

HUMUEC
Market Cap
$46.49B$4.53B
Volume
2,567,70410,888,578
Sector
HealthEnergy
52-Week High
$409.85$20.14
52-Week Low
$163.67$9.04
Typical Hold Time
53 Days37 Days
Enterprise Value
$53.84B$4.03B
Dividend Yield
0.91%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Humana Inc

Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.

The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.

Uranium Energy Corp

UEC trades at $9.24, down 2.43% on the day, amid a bearish technical signal with moving averages indicating selling pressure. The company reported a net loss of -$87.66M in 2025, with revenue of $66.84M and a deeply negative net income margin of -368.62%. Recent news highlights operational expansion to two mines, but earnings misses in Q1 and Q2 2026 raise concerns about sustainability despite a Q4 beat.

Wall Street analysts remain bullish with an 87.5% buy rating and a $16.06 consensus price target, citing U.S. uranium demand growth. However, high cash burn, reliance on financing, and unproven production sustainability pose significant risks. The stock offers speculative upside if operational execution improves, but current fundamentals warrant caution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HUM

No sentiment data available yet.

UEC
57% Buy43% Sell
Avg holding period · 37 Days

Top news

Latest headlines on both assets

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM →

About Uranium Energy Corp

Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.

Read more on UEC →